Cargando…

Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma

In Norway, nodular melanoma is the most fatal melanoma subtype and superficial spreading melanoma the most common, indicating diagnostic challenges. The aim of this study was to assess the clinical suspicion sensitivity of nodular melanoma and superficial spreading melanoma, by diagnosing physician,...

Descripción completa

Detalles Bibliográficos
Autores principales: ROBSAHM, Trude E., HELSING, Per, SVENDSEN, Henrik L., VEIERØD, Marit B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364251/
https://www.ncbi.nlm.nih.gov/pubmed/33686445
http://dx.doi.org/10.2340/00015555-3782
_version_ 1784765109486223360
author ROBSAHM, Trude E.
HELSING, Per
SVENDSEN, Henrik L.
VEIERØD, Marit B.
author_facet ROBSAHM, Trude E.
HELSING, Per
SVENDSEN, Henrik L.
VEIERØD, Marit B.
author_sort ROBSAHM, Trude E.
collection PubMed
description In Norway, nodular melanoma is the most fatal melanoma subtype and superficial spreading melanoma the most common, indicating diagnostic challenges. The aim of this study was to assess the clinical suspicion sensitivity of nodular melanoma and superficial spreading melanoma, by diagnosing physician, using randomly selected 100 nodular melanomas and 100 superficial spreading melanomas from the Norwegian Melanoma Registry, diagnosed in 2014 to 2015. Information about suggested diagnoses and diagnosing physician was collected from pathology request forms. Suspicion sensitivity was defined as the proportion (%) of cases with “melanoma” as a suggested diagnosis, estimated with 95% confidence interval (95% CI). Most melanomas (74.5%) were diagnosed by non-dermatologists, with a suspicion sensitivity of 23% (95% CI 15–34) for nodular melanoma and 24% (95% CI 16–35) for superficial spreading melanoma. Corresponding estimates for dermatologists were 50% (95% CI 32–68) and 96% (95% CI 80–99), respectively (p(interaction)=0.007). The low suspicion sensitivity for both subtypes among non-dermatologists calls for educational efforts.
format Online
Article
Text
id pubmed-9364251
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Society for Publication of Acta Dermato-Venereologica
record_format MEDLINE/PubMed
spelling pubmed-93642512022-10-20 Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma ROBSAHM, Trude E. HELSING, Per SVENDSEN, Henrik L. VEIERØD, Marit B. Acta Derm Venereol Clinical Report In Norway, nodular melanoma is the most fatal melanoma subtype and superficial spreading melanoma the most common, indicating diagnostic challenges. The aim of this study was to assess the clinical suspicion sensitivity of nodular melanoma and superficial spreading melanoma, by diagnosing physician, using randomly selected 100 nodular melanomas and 100 superficial spreading melanomas from the Norwegian Melanoma Registry, diagnosed in 2014 to 2015. Information about suggested diagnoses and diagnosing physician was collected from pathology request forms. Suspicion sensitivity was defined as the proportion (%) of cases with “melanoma” as a suggested diagnosis, estimated with 95% confidence interval (95% CI). Most melanomas (74.5%) were diagnosed by non-dermatologists, with a suspicion sensitivity of 23% (95% CI 15–34) for nodular melanoma and 24% (95% CI 16–35) for superficial spreading melanoma. Corresponding estimates for dermatologists were 50% (95% CI 32–68) and 96% (95% CI 80–99), respectively (p(interaction)=0.007). The low suspicion sensitivity for both subtypes among non-dermatologists calls for educational efforts. Society for Publication of Acta Dermato-Venereologica 2021-04-12 /pmc/articles/PMC9364251/ /pubmed/33686445 http://dx.doi.org/10.2340/00015555-3782 Text en © 2021 Acta Dermato-Venereologica https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the CC BY-NC license
spellingShingle Clinical Report
ROBSAHM, Trude E.
HELSING, Per
SVENDSEN, Henrik L.
VEIERØD, Marit B.
Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma
title Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma
title_full Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma
title_fullStr Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma
title_full_unstemmed Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma
title_short Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma
title_sort clinical suspicion sensitivity of nodular and superficial spreading melanoma
topic Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364251/
https://www.ncbi.nlm.nih.gov/pubmed/33686445
http://dx.doi.org/10.2340/00015555-3782
work_keys_str_mv AT robsahmtrudee clinicalsuspicionsensitivityofnodularandsuperficialspreadingmelanoma
AT helsingper clinicalsuspicionsensitivityofnodularandsuperficialspreadingmelanoma
AT svendsenhenrikl clinicalsuspicionsensitivityofnodularandsuperficialspreadingmelanoma
AT veierødmaritb clinicalsuspicionsensitivityofnodularandsuperficialspreadingmelanoma